CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase 1 Trial of MK-2870 as Monotherapy and in Combination With Pembrolizumab ± Chemotherapy in Subjects With Advanced Solid Tumors
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06049212
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:29:09.462106+00:00
- Published At
- 2026-04-16T00:00:00+00:00
- Record Updated At
- 2026-04-16
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Non-small Cell Lung Cancer", "Solid Tumors", "Programmed Cell Death-1 (PD1, PD-1)", "Programmed Cell Death 1 Ligand 1(PDL1, PD-L1)", "Programmed Cell Death 1 Ligand 2 (PDL2, PD-L2)"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-16"- protocolSection.identificationModule.nctId
"NCT06049212"- protocolSection.identificationModule.officialTitle
"Phase 1 Trial of MK-2870 as Monotherapy and in Combination With Pembrolizumab \u00b1 Chemotherapy in Subjects With Advanced Solid Tumors"- protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.